Islet cell function in type 1 and type 2 diabetes

被引:0
作者
Hao, W [1 ]
Palmer, JP [1 ]
机构
[1] Dept Vet Affairs, Puget Sound Hlth Care Syst, Seattle, WA 98108 USA
来源
JOURNAL OF CLINICAL LIGAND ASSAY | 1998年 / 21卷 / 03期
关键词
diabetes; insulin; C-peptide; glucose; arginine; glucagon; insulin sensitivity; beta cell function; insulin secretion;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The primary hormone controlling glucose metabolism is insulin. A deficiency in insulin secretion is a central defect in the pathophysiology of both type 1 and type 2 diabetes. In this review we discuss the abnormalities of insulin secretion characteristic of both forms of diabetes. We describe most of the commonly employed tests of beta cell function and explore their relative advantages and disadvantages. Usually, there is a trade-off between the complexity of the test and the amount of information obtained. For example, measuring insulin or C-peptide during the fasting state provides far less information on total beta cell functional capacity than does dynamic beta cell testing at different glucose levels using several intravenous beta cell secretagogues. Since insulin and C-peptide are the primary measurements used during beta cell testing, a few caveats are provided regarding both of these assays and the interpretation of results.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 79 条
[1]   REMISSION IN IDDM - PROSPECTIVE-STUDY OF BASAL C-PEPTIDE AND INSULIN DOSE IN 268 CONSECUTIVE PATIENTS [J].
AGNER, T ;
DAMM, P ;
BINDER, C .
DIABETES CARE, 1987, 10 (02) :164-169
[2]   THE INSULIN SENSITIVITY INDEX IN NONDIABETIC MAN - CORRELATION BETWEEN CLAMP-DERIVED AND IVGTT-DERIVED VALUES [J].
BEARD, JC ;
BERGMAN, RN ;
WARD, WK ;
PORTE, D .
DIABETES, 1986, 35 (03) :362-369
[3]   EQUIVALENCE OF THE INSULIN SENSITIVITY INDEX IN MAN DERIVED BY THE MINIMAL MODEL METHOD AND THE EUGLYCEMIC GLUCOSE CLAMP [J].
BERGMAN, RN ;
PRAGER, R ;
VOLUND, A ;
OLEFSKY, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :790-800
[4]  
Bergman RN, 1979, AM J PHYSIOL, V236, P667
[5]   STANDARDIZATION OF IVGTT TO PREDICT IDDM [J].
BINGLEY, PJ ;
COLMAN, P ;
EISENBARTH, GS ;
JACKSON, RA ;
MCCULLOCH, DK ;
RILEY, WJ ;
GALE, EAM .
DIABETES CARE, 1992, 15 (10) :1313-1316
[6]   CAN ISLET CELL ANTIBODIES PREDICT IDDM IN THE GENERAL-POPULATION [J].
BINGLEY, PJ ;
BONIFACIO, E ;
SHATTOCK, M ;
GILLMOR, HA ;
SAWTELL, PA ;
DUNGER, DB ;
SCOTT, RDM ;
BOTTAZZO, GF ;
GALE, EAM .
DIABETES CARE, 1993, 16 (01) :45-50
[7]   CAN WE REALLY PREDICT IDDM [J].
BINGLEY, PJ ;
BONIFACIO, E ;
GALE, EAM .
DIABETES, 1993, 42 (02) :213-220
[8]  
BINGLEY PJ, 1989, DIABETES S2, V38, pA86
[9]   ISLET-CELL ANTIBODIES IN DIABETES-MELLITUS WITH AUTOIMMUNE POLY-ENDOCRINE DEFICIENCIES [J].
BOTTAZZO, GF ;
FLORINCH.A ;
DONIACH, D .
LANCET, 1974, 2 (7892) :1279-1283
[10]   RELATIONSHIPS BETWEEN FASTING PLASMA GLUCOSE LEVELS AND INSULIN-SECRETION DURING INTRAVENOUS GLUCOSE-TOLERANCE TESTS [J].
BRUNZELL, JD ;
ROBERTSON, RP ;
LERNER, RL ;
HAZZARD, WR ;
ENSINCK, JW ;
BIERMAN, EL ;
PORTE, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (02) :222-229